J05AX23 ibalizumab
ATC group of level 5 – chemical substance · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 1 medicine in this group.
Active substance: Ibalizumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
- J05AX Other antivirals 27 medicines
- J05AX23 ibalizumab 1 medicine
- J05AX Other antivirals 27 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Trogarzo 200 mg concentrate for solution for infusion SPC | – |
Other groups of the same level
- J05AX05 inosine pranobex 1 medicine
- J05AX07 enfuvirtide 1 medicine
- J05AX09 maraviroc 8 medicines
- J05AX10 maribavir 1 medicine
- J05AX18 letermovir 6 medicines
- J05AX24 tecovirimat 1 medicine
- J05AX25 baloxavir marboxil 3 medicines
- J05AX28 bulevirtide 1 medicine
- J05AX29 fostemsavir 1 medicine
Other names of the ATC group
- German: J05AX23 Ibalizumab
- German: J05AX23 Ibalizumab
- Turkish: J05AX23 ibalizumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AX23
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.